רוזובסטטין טבע ® 20 מ"ג Israel - Tiếng Do Thái - Ministry of Health

רוזובסטטין טבע ® 20 מ"ג

teva pharmaceutical indust.ltd - rosuvastatin as calcium 20 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

רוזובסטטין טבע ® 40 מ"ג Israel - Tiếng Do Thái - Ministry of Health

רוזובסטטין טבע ® 40 מ"ג

teva pharmaceutical indust.ltd - rosuvastatin as calcium 40 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

לקסיבה Israel - Tiếng Do Thái - Ministry of Health

לקסיבה

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

לקסיבה Israel - Tiếng Do Thái - Ministry of Health

לקסיבה

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

CAPD 17 תמיסה לדיאליזה צפקית Israel - Tiếng Do Thái - Ministry of Health

capd 17 תמיסה לדיאליזה צפקית

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - magnesium chloride 0.1017 g; calcium chloride 0.1838 g; glucose as monohydrate 16.5 g; lactic acid as sodium 3.925 g; sodium chloride 5.786 g - combinations - combinations - for use in patients with end-stage (decompersated )chronic renal failure of any origin which can be treated with peritoneal dealysis.

CAPD 18 תמיסה לדיאליזה צפקית Israel - Tiếng Do Thái - Ministry of Health

capd 18 תמיסה לדיאליזה צפקית

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.786 g; lactic acid as sodium 3.925 g; glucose as monohydrate 46.75 g; calcium chloride 0.1838 g; magnesium chloride 0.1017 g - combinations - combinations - for use in patients with end-stage (decompersated )chronic renal failure of any origin which can be treated with peritoneal dealysis.

CAPD 19 תמיסה לדיאליזה צפקית Israel - Tiếng Do Thái - Ministry of Health

capd 19 תמיסה לדיאליזה צפקית

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - magnesium chloride 0.1017 g; glucose as monohydrate 25 g; calcium chloride 0.1838 g; sodium chloride 5.786 g; lactic acid as sodium 3.925 g - combinations - combinations - for use in patients with end-stage (decompersated )chronic renal failure of any origin which can be treated with peritoneal dealysis.

פיזיוניל 40 גלוקוז % 1.36 Israel - Tiếng Do Thái - Ministry of Health

פיזיוניל 40 גלוקוז % 1.36

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

פיזיוניל 40 גלוקוז % 2.27 Israel - Tiếng Do Thái - Ministry of Health

פיזיוניל 40 גלוקוז % 2.27

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium chloride 5.38 g/l; glucose monohydrate (as anhydrous) 22.7 g/l; calcium chloride dihydrate 0.184 g/l; lactic acid as sodium 1.68 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium bicarbonate 2.10 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

CAPD - 2 תמיסה לדיאליזה צפקית Israel - Tiếng Do Thái - Ministry of Health

capd - 2 תמיסה לדיאליזה צפקית

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 16.5 g/l; lactic acid as sodium 3.925 g/l - combinations of electrolytes - combinations of electrolytes - for patients with (decompensated) chronic renal failure being maintained on peritoneal dialysis.